PharmaCielo (PCLOF) Stock Price, News & Analysis

Company Overview

PharmaCielo is a vertically integrated medical cannabis company that specializes in the cultivation, extraction and production of high-purity cannabinoid ingredients for global pharmaceutical and wellness markets. The company’s operations encompass the full value chain, from seed selection and greenhouse cultivation to post-harvest processing and quality assurance. By employing advanced extraction techniques, PharmaCielo produces distillates, isolates and full-spectrum extracts designed for use in licensed medical cannabis programs and research applications.

Founded in 2013 and headquartered in Vancouver, PharmaCielo operates large-scale cultivation facilities in the Caquetá region of Colombia, where favorable climate and agricultural conditions support year-round production. The company’s Colombian operations are certified under local Good Agricultural and Collection Practices (GACP) guidelines, with ongoing efforts to secure Good Manufacturing Practices (GMP) certification for its extraction laboratories. This regulatory focus underpins PharmaCielo’s commitment to consistency, safety and traceability in its product offerings.

PharmaCielo’s portfolio includes refined cannabis oils tailored to pharmaceutical, nutraceutical and cosmetic applications. The company serves domestic and export markets, supplying registered producers and pharmaceutical partners in Canada, Europe, Latin America and Australasia. In addition to its core extraction business, PharmaCielo collaborates with research institutions to develop novel cannabinoid formulations and to explore emerging therapeutic applications, including pain management and neurological disorders.

Under the leadership of Chief Executive Officer Steven Martin, PharmaCielo has forged strategic partnerships and distribution agreements to expand its global footprint. The management team combines expertise in agriculture, biochemistry and international regulatory affairs to navigate complex market requirements and to scale production capacity. Looking ahead, PharmaCielo aims to strengthen its position in the medical cannabis sector by advancing product innovation and by extending its supply chain to new geographies and end-use markets.

Key Stats

• Today's Range: $0.03 to $0.04
• 50-Day Range: $0.03 to $0.05
• 52-Week Range: $0.02 to $0.15
• Volume: 186,345 shs
• Average Volume: 39,701 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PCLOF Stock Analysis - Frequently Asked Questions

How have PCLOF shares performed this year?

PharmaCielo's stock was trading at $0.0521 at the beginning of 2025. Since then, PCLOF shares have decreased by 28.6% and is now trading at $0.0372.

How do I buy shares of PharmaCielo?

Shares of PCLOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:PCLOF
• CIK: N/A
• Web: www.pharmacielo.com
• Phone: (416) 562-3220
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A